The Outlook for Pharmaceuticals in South East Asia

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 129 pages

BMI View: Singapore is a low risk pharmaceutical industry thanks to political stability and pro-business policies that continue to attract risk adverse investors. Despite high per capita expenditure on healthcare and a developed healthcare system, the small population size will limit long-term industry ...

Industries: Drug and Medication | Countries: Singapore

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

  • $ 7 995
  • Industry report
  • by Global Data
  • July 2014
  • 188 pages

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million ...

Industries: Drug and Medication | Countries: Singapore, Brazil, India, Mexico, Thailand, World

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • May 2014
  • 131 pages

Includes 3 FREE quarterly updates BMI View: The reduction in healthcare subsidies for permanent residents (PRs) in Singapore, which is to be implemented in two phases over the coming 12 months, is a politically driven move rather than a genuine restructuring of the public healthcare system. The policy ...

Industries: Drug and Medication | Countries: Singapore

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 39 pages

Summary Emcure Pharmaceuticals Ltd. (Emcure) is a pharmaceutical company. The company develops, manufactures and markets health care products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante, Neuroscience, Global HIV, Pharma, Gennova, Oncocare, and APIs. Emcure offers APIs such as acamprosate ...

Industries: Drug and Medication | Countries: India, World, Singapore, South Africa

NRT Smoking Cessation Aids Market Overview in Singapore

NRT Smoking Cessation Aids Market Overview in Singapore

  • $ 718
  • Industry report
  • by Euromonitor International
  • May 2014
  • 21 pages

In April 2010, the Ministry of Health (MOH) made changes to the Smoking (Control of Advertisements and Sale of Tobacco) Act in Parliament. The objective of the amendment bill was to strengthen tobacco control. The main changes included more stringent regulations on the import and distribution of tobacco ...

Industries: Drug and Medication | Countries: Singapore

Analgesics Market Overview in Singapore

Analgesics Market Overview in Singapore

  • $ 718
  • Industry report
  • by Euromonitor International
  • May 2014
  • 26 pages

Topical analgesics brands were aggressively industry ed in 2010, which contributed to their better performance compared to systemic analgesics. Salonpas, which is industry ed by Hisamitsu Pharmaceutical Co Inc, launched a major industry ing campaign in 2010. Even brands such as Axe, which did not engage ...

Industries: Drug and Medication | Countries: Singapore

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Singapore

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Singapore

  • $ 718
  • Industry report
  • by Euromonitor International
  • May 2014
  • 24 pages

There was increased industry ing and advertising for cough, cold and allergy (hay fever) remedies in the latter part of the review period. For instance, several brands within cough remedies were supported by television and radio advertisements. African Sea Coconut, which is industry ed by Luen Fook Medicine ...

Industries: Drug and Medication | Countries: Singapore

Orphan Drugs in Asia 2014

Orphan Drugs in Asia 2014

  • $ 1 500
  • Industry report
  • by Pacific Bridge Medical
  • March 2014
  • 148 pages

Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan Drug Exemption to the Medicines Act and Japan's Orphan Drug Amendment to the Pharmaceutical Affairs Law. While laws on orphan drugs in Asia ...

Industries: Drug and Medication | Countries: Asia, Japan, South Korea, Taiwan, China, World, Philippines, Singapore, United States, Malaysia, Vietnam, Thailand

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • March 2014
  • 129 pages

BMI View: Singapore is a well-developed pharmaceutical industry, although overall revenues only reached a modest SGD901mn (US Dollar 716mn) in 2011, on account of the small population of the city-state. Nevertheless, the government will continue to prioritise research and biomedical manufacturing, which ...

Industries: Drug and Medication | Countries: Singapore

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2013
  • 130 pages

BMI View: We commend initiatives launched by Singapore's government to ease the financial burden of healthcare on lower-income patients. However, the limited number of hospital beds and disproportionately high private healthcare expenditure will continue to put pressure on patients. BMI believes Singapore's ...

Industries: Drug and Medication | Countries: Singapore

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.